$2.96
-0.17-5.27%
At close: -
$2.97
0.005000.17%
After Hours: Feb 21, 5:28 PM EDT
Prime Medicine reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Prime Medicine using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.44 | $-0.39 | -12.8 % |
Q2 | 2024-08-08 | $-0.46 | $-0.41 | -12.2 % |
Q1 | 2024-05-10 | $-0.44 | $-0.47 | 6.38 % |
Q4 | 2024-03-01 | $-0.72 | $-0.51 | -41.2 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q2 | 2024-08-08 | $0 | $1.63M | -100.0 % |
Prime Medicine (PRME) is scheduled to report earnings on May 9, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.44, which missed the estimate of $-0.39.
The Actual Revenue was $209K, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.